Literature DB >> 17665514

Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women.

Steve E Humphries1, David Gable, Jackie A Cooper, Helen Ireland, Jeffrey W Stephens, Steven J Hurel, Ka Wah Li, Jutta Palmen, Michelle A Miller, Francesco P Cappuccio, Robert Elkeles, Ian Godsland, George J Miller, Philippa J Talmud.   

Abstract

Common variants of TCF7L2, encoding a beta-cell-expressed transcription factor, are strongly associated with increased risk of type 2 diabetes (T2D). We examined this association using both prospective and case-control designs. A total of 2,676 healthy European white middle-aged men from the prospective NPHSII (158 developed T2D over 15 years surveillance) were genotyped for two intronic SNPs [rs 7903146 (IVS3C>T) and rs12255372 (IVS4G>T)] which showed strong linkage disequilibrium (D' = 0.88, p<0.001; R(2)=0.76, p<0.001). The IVS5T allele frequency was 0.28 (95% CI 0.27-0.29) and 0.33 (0.28-0.39) in healthy and T2D, respectively (p=0.04). Compared to CC men, CT and TT men had an adjusted [for age, body mass index, systolic blood pressure, triglyceride and C-reactive protein levels] hazard ratio for T2D of 1.65 (1.13-2.41) and 1.87 (0.99-3.53), respectively, p<0.01. The population attributable fraction for diabetes risk was 17%. In 1459, European white T2D men and women (60% male), T allele frequency was 0.36 (0.34-0.38), and compared to NPHSII healthy men the OR for T2D for the CT and TT subjects was 1.43 (1.24-1.65) and 2.11 (1.69-2.63), respectively p=<0.0001. A similar effect was observed in 919 T2D Indian Asians [OR=1.50 (1.14-1.99) and 1.64 (1.03-2.63) p=0.003] and 385 Afro-Caribbean subjects [OR=1.25 (0.90-1.75) and 1.32 (0.74-2.33) p=0.17] compared to non-diabetic ethnically matched subjects from South London. Weaker associations were found for the IVS4G>T in all studies. Linkage disequilibrium between the two SNPs was high in Indian Asians (D'=0.94), but much weaker in Afro-Caribbeans (D'=0.17) and haplotype frequencies differed markedly in this group. These results extend previous observations to other ethnic groups, and strongly confirm that TCF7L2 genotype is a major risk factor for development of T2D.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17665514     DOI: 10.1007/s00109-006-0108-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  27 in total

1.  In search of genetic precision.

Authors:  Steve E Humphries; Emma Hawe; Sukhbir Dhamrait; George J Miller; Philippa J Talmud
Journal:  Lancet       Date:  2003-05-31       Impact factor: 79.321

2.  Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm.

Authors:  D-A Tregouet; L Tiret
Journal:  Eur J Hum Genet       Date:  2004-11       Impact factor: 4.246

3.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

4.  Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation.

Authors:  R Scott Heller; Darwin S Dichmann; Jan Jensen; Chris Miller; Gordon Wong; Ole D Madsen; Palle Serup
Journal:  Dev Dyn       Date:  2002-11       Impact factor: 3.780

5.  Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men.

Authors:  David R Gable; Jefferey W Stephens; Jackie A Cooper; George J Miller; Steve E Humphries
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

6.  Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.

Authors:  David M Flavell; Helen Ireland; Jeffrey W Stephens; Emma Hawe; Jay Acharya; Hugh Mather; Steven J Hurel; Steve E Humphries
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

7.  The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study).

Authors:  R S Elkeles; M D Feher; M D Flather; I F Godsland; F Nugara; W Richmond; M B Rubens; D Wang
Journal:  Diabet Med       Date:  2004-10       Impact factor: 4.359

8.  Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2.

Authors:  Inga Reynisdottir; Gudmar Thorleifsson; Rafn Benediktsson; Gunnar Sigurdsson; Valur Emilsson; Anna Sigurlin Einarsdottir; Eyrun Edda Hjorleifsdottir; Gudbjorg Th Orlygsdottir; Gudrun Thora Bjornsdottir; Jona Saemundsdottir; Skarphedinn Halldorsson; Soffia Hrafnkelsdottir; Steinunn Bjorg Sigurjonsdottir; Svana Steinsdottir; Mitchell Martin; Jarema P Kochan; Brian K Rhees; Struan F A Grant; Michael L Frigge; Augustine Kong; Vilmundur Gudnason; Kari Stefansson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2003-07-08       Impact factor: 11.025

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.

Authors:  V Korinek; N Barker; P Moerer; E van Donselaar; G Huls; P J Peters; H Clevers
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

View more
  64 in total

Review 1.  Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.

Authors:  Ola Hansson; Yuedan Zhou; Erik Renström; Peter Osmark
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

Review 2.  Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Authors:  M A Daniels; C Kan; D M Willmes; K Ismail; F Pistrosch; D Hopkins; G Mingrone; S R Bornstein; A L Birkenfeld
Journal:  Pharmacogenomics J       Date:  2016-07-19       Impact factor: 3.550

3.  A high mobility group box-containing transcription factor leads to diabetes risk.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2006-11-08       Impact factor: 4.599

Review 4.  Pharmacogenetics: potential role in the treatment of diabetes and obesity.

Authors:  Adrian Vella; Michael Camilleri
Journal:  Expert Opin Pharmacother       Date:  2008-05       Impact factor: 3.889

5.  Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.

Authors:  Jason H Karnes; Yan Gong; Michael A Pacanowski; Caitrin W McDonough; Meghan J Arwood; Taimour Y Langaee; Carl J Pepine; Julie A Johnson; Rhonda M Cooper-Dehoff
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089

6.  A genomics study of type 2 diabetes mellitus in U.S. Air Force personnel.

Authors:  Lisa Lott
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

7.  Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent.

Authors:  S C Elbein; W S Chu; S K Das; A Yao-Borengasser; S J Hasstedt; H Wang; N Rasouli; P A Kern
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

8.  Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia.

Authors:  Daruneewan Warodomwichit; Donna K Arnett; Edmond K Kabagambe; Michael Y Tsai; James E Hixson; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Ingrid Borecki; Jose M Ordovas
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

9.  TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population.

Authors:  G F Marquezine; A C Pereira; A G P Sousa; J G Mill; W A Hueb; J E Krieger
Journal:  BMC Med Genet       Date:  2008-12-04       Impact factor: 2.103

10.  Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and Caucasian adults: the Atherosclerosis Risk in Communities study.

Authors:  Yu Yan; Kari E North; Christie M Ballantyne; Frederick L Brancati; Lloyd E Chambless; Nora Franceschini; Gerardo Heiss; Anna Kottgen; James S Pankow; Elizabeth Selvin; Suzanne L West; Eric Boerwinkle
Journal:  Diabetes       Date:  2008-10-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.